Portal:COVID-19


  New related articles 

The COVID-19 portal

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

The WHO ended the PHEIC for COVID-19 on 5 May 2023. The disease has continued to circulate. However, as of 2024, experts were uncertain as to whether it was still a pandemic. Pandemics and their ends are not well-defined, and whether or not one has ended differs according to the definition used. As of 6 August 2025, COVID-19 has caused 7,098,256[1] confirmed deaths, and 18.2 to 33.5 million estimated deaths. The COVID-19 pandemic ranks as the fifth-deadliest pandemic or epidemic in history. (Full article)

About the virus

SARS‑CoV‑2 belongs to the broad family of viruses known as coronaviruses. It is a positive-sense single-stranded RNA (+ssRNA) virus, with a single linear RNA segment. Coronaviruses infect humans, other mammals, including livestock and companion animals, and avian species. Human coronaviruses are capable of causing illnesses ranging from the common cold to more severe diseases such as Middle East respiratory syndrome (MERS, fatality rate ~34%). SARS-CoV-2 is the seventh known coronavirus to infect people, after 229E, NL63, OC43, HKU1, MERS-CoV, and the original SARS-CoV.

Like the SARS-related coronavirus implicated in the 2003 SARS outbreak, SARS‑CoV‑2 is a member of the subgenus Sarbecovirus (beta-CoV lineage B). Coronaviruses undergo frequent recombination. The mechanism of recombination in unsegmented RNA viruses such as SARS-CoV-2 is generally by copy-choice replication, in which gene material switches from one RNA template molecule to another during replication. The SARS-CoV-2 RNA sequence is approximately 30,000 bases in length, relatively long for a coronavirus—which in turn carry the largest genomes among all RNA families. Its genome consists nearly entirely of protein-coding sequences, a trait shared with other coronaviruses. (Full article)

Disease progress

As of 6 August 2025, 778,344,590 cases of COVID-19 have been reported, resulting in 7,098,256 reported deaths.[1]


Updated August 6, 2025.
COVID-19 pandemic by location[1]
Location Cases Deaths
World[a] 778,344,590 7,098,256
European Union[b] 186,633,043 1,268,557
United States 103,436,829 1,225,706
China[c] 99,381,761 122,398
India 45,055,713 533,825
France 39,041,914 168,162
Germany 38,437,870 174,979
Brazil 37,755,316 702,986
South Korea 34,571,873 35,934
Japan 33,803,572 74,694
Italy 26,968,605 198,523
United Kingdom 25,060,111 232,112
Russia 24,901,467 404,290
Turkey 17,004,718 101,419
Spain 13,980,340 121,852
Australia 11,861,161 25,236
Vietnam 11,624,000 43,206
Argentina 10,113,670 130,782
Taiwan 9,970,937 17,672
Netherlands 8,651,352 22,986
Mexico 7,628,171 334,974
Iran 7,627,863 146,837
Indonesia 6,830,274 162,059
Poland 6,781,741 120,981
Colombia 6,399,563 142,782
Austria 6,083,153 22,534
Greece 5,781,348 40,080
Portugal 5,671,586 29,283
Ukraine 5,543,759 109,925
Chile 5,410,169 64,497
Thailand 5,384,888 34,980
Malaysia 5,329,836 37,351
Belgium 4,897,620 34,339
Israel 4,841,558 12,707
Czech Republic 4,833,778 43,816
Canada 4,819,055 55,282
Peru 4,532,664 221,058
Switzerland 4,479,378 14,170
Philippines 4,173,631 66,864
South Africa 4,072,974 102,595
Romania 3,570,231 68,965
Denmark 3,447,873 10,012
Singapore 3,006,155 2,024
Hong Kong 2,876,106 13,466
Sweden 2,776,517 28,818
New Zealand 2,668,236 4,538
Serbia 2,567,965 18,057
Iraq 2,465,545 25,375
Hungary 2,238,059 49,124
Bangladesh 2,052,246 29,526
Slovakia 1,886,074 21,282
Georgia 1,864,383 17,151
Republic of Ireland 1,757,269 9,840
Jordan 1,746,997 14,122
Pakistan 1,580,631 30,656
Norway 1,539,178 5,732
Finland 1,512,347 11,466
Kazakhstan 1,504,370 19,072
Lithuania 1,427,062 9,884
Slovenia 1,363,345 9,914
Croatia 1,357,359 18,784
Bulgaria 1,338,490 38,765
Morocco 1,279,115 16,305
Guatemala 1,253,386 20,205
Puerto Rico 1,252,713 5,938
Lebanon 1,239,904 10,947
Costa Rica 1,238,916 9,386
Bolivia 1,212,173 22,389
Tunisia 1,153,361 29,423
Cuba 1,113,720 8,530
Ecuador 1,080,371 36,060
United Arab Emirates 1,067,030 2,349
Panama 1,045,458 8,799
Uruguay 1,042,815 7,695
Mongolia 1,011,489 2,136
Nepal 1,003,826 12,033
Belarus 994,052 7,118
Latvia 977,782 7,613
Saudi Arabia 841,469 9,646
Azerbaijan 836,510 10,353
Paraguay 735,759 19,880
Cyprus 713,897 1,364
Palestine 703,228 5,708
Bahrain 696,614 1,536
Sri Lanka 672,812 16,907
Kuwait 667,290 2,570
Dominican Republic 661,103 4,384
Moldova 651,074 12,284
Myanmar 643,397 19,494
Estonia 614,816 3,150
Venezuela 552,743 5,856
Egypt 516,023 24,830
Qatar 514,524 690
Libya 507,269 6,437
Ethiopia 501,317 7,574
Réunion 494,595 921
Honduras 472,981 11,114
Armenia 454,363 8,785
Bosnia and Herzegovina 404,287 16,406
Oman 399,449 4,628
Luxembourg 398,269 1,000
North Macedonia 352,093 9,991
Brunei 350,550 182
Zambia 349,892 4,078
Kenya 344,136 5,689
Albania 337,198 3,608
Mauritius 332,068 1,074
Botswana 330,699 2,801
Kosovo 274,279 3,212
Algeria 272,370 6,881
Nigeria 267,215 3,155
Zimbabwe 266,434 5,740
Montenegro 251,280 2,654
Afghanistan 235,214 7,998
Mozambique 233,909 2,252
Martinique 230,354 1,104
Laos 219,060 671
Iceland 210,916 186
Guadeloupe 203,235 1,021
El Salvador 202,029 4,230
Trinidad and Tobago 191,496 4,390
Maldives 186,694 316
Uzbekistan 175,119 1,016
Ghana 172,701 1,463
Namibia 172,557 4,110
Uganda 172,206 3,632
Jamaica 157,604 3,628
Cambodia 139,326 3,056
Rwanda 133,268 1,468
Cameroon 125,311 1,974
Malta 124,346 1,041
Barbados 108,921 593
Angola 107,487 1,937
Democratic Republic of the Congo 101,010 1,474
French Guiana 98,041 413
Senegal 89,385 1,972
Malawi 89,168 2,686
Kyrgyzstan 88,953 1,024
Ivory Coast 88,434 835
Suriname 82,515 1,406
New Caledonia 80,203 314
French Polynesia 79,451 650
Guyana 75,479 1,312
Eswatini 75,356 1,427
Belize 71,482 688
Fiji 69,047 885
Madagascar 68,692 1,428
Jersey 66,391 161
Cabo Verde 64,474 417
Sudan 63,993 5,046
Mauritania 63,891 997
Bhutan 63,075 21
Syria 57,423 3,163
Burundi 54,569 15
Guam 52,287 419
Seychelles 51,899 172
Gabon 49,069 307
Andorra 48,015 159
Papua New Guinea 46,864 670
Curaçao 45,883 305
Aruba 44,224 292
Tanzania 43,545 846
Mayotte 42,027 187
Togo 39,553 290
Bahamas 39,127 849
Guinea 38,593 468
Isle of Man 38,008 116
Lesotho 36,140 709
Guernsey 35,326 67
Haiti 34,797 860
Faroe Islands 34,658 28
Mali 33,197 743
Federated States of Micronesia 31,765 65
Cayman Islands 31,472 37
Saint Lucia 30,248 410
Benin 28,036 163
Somalia 27,334 1,361
Solomon Islands 25,954 199
United States Virgin Islands 25,389 132
San Marino 25,292 126
Republic of the Congo 25,234 389
Timor-Leste 23,460 138
Burkina Faso 22,213 400
Liechtenstein 21,624 89
Gibraltar 20,550 113
Grenada 19,693 238
South Sudan 18,873 147
Bermuda 18,860 165
Tajikistan 17,786 125
Monaco 17,181 67
Equatorial Guinea 17,130 183
Samoa 17,057 31
Tonga 16,992 13
Nicaragua 16,398 245
Marshall Islands 16,297 17
Dominica 16,047 74
Djibouti 15,690 189
Central African Republic 15,486 113
Northern Mariana Islands 14,985 41
Gambia 12,627 372
Collectivity of Saint Martin 12,324 46
Vanuatu 12,019 14
Greenland 11,971 21
Yemen 11,945 2,159
Caribbean Netherlands 11,922 41
Sint Maarten 11,051 92
Eritrea 10,189 103
Saint Vincent and the Grenadines 9,674 124
Guinea-Bissau 9,614 177
Niger 9,573 315
Comoros 9,109 161
Antigua and Barbuda 9,106 146
American Samoa 8,359 34
Liberia 8,090 294
Sierra Leone 7,985 126
Chad 7,702 194
British Virgin Islands 7,652 64
Cook Islands 7,375 2
Turks and Caicos Islands 6,911 41
Sao Tome and Principe 6,771 80
Saint Kitts and Nevis 6,607 46
Palau 6,372 10
Saint Barthélemy 5,507 5
Nauru 5,393 1
Kiribati 5,085 24
Anguilla 3,904 12
Wallis and Futuna 3,760 9
Macau 3,514 121
Saint Pierre and Miquelon 3,426 2
Tuvalu 2,943 1
Saint Helena, Ascension and Tristan da Cunha 2,166 0
Falkland Islands 1,923 0
Montserrat 1,403 8
Niue 1,092 0
Tokelau 80 0
Vatican City 26 0
Pitcairn Islands 4 0
Turkmenistan 0 0
North Korea 0 0
  1. ^ Countries which do not report data for a column are not included in that column's world total.
  2. ^ Data on member states of the European Union are individually listed, but are also summed here for convenience. They are not double-counted in world totals.
  3. ^ Does not include special administrative regions (Hong Kong and Macau) or Taiwan.

About the symptoms

The symptoms of COVID-19 are variable depending on the type of variant contracted, ranging from mild symptoms to a potentially fatal illness. Common symptoms include coughing, fever, loss of smell (anosmia) and taste (ageusia), with less common ones including headaches, nasal congestion and runny nose, muscle pain, sore throat, diarrhea, eye irritation, and toes swelling or turning purple, and in moderate to severe cases, breathing difficulties. People with the COVID-19 infection may have different symptoms, and their symptoms may change over time. (Full article)

About the spread

Infected people exhale those particles as they breathe, talk, cough, sneeze, or sing. Transmission is most likely at closer range but, can also occur can occur over longer distances, particularly indoors.

Infectious particles range in size from aerosols that remain suspended in the air for long periods of time to larger droplets that remain airborne briefly or fall to the ground. Additionally, COVID-19 research has redefined the traditional understanding of how respiratory viruses are transmitted. The largest droplets of respiratory fluid do not travel far, but can be inhaled or land on mucous membranes on the eyes, nose, or mouth to infect. Aerosols are highest in concentration when people are in close proximity, which leads to easier viral transmission when people are physically close, but airborne transmission can occur at longer distances, mainly in locations that are poorly ventilated; in those conditions small particles can remain suspended in the air for minutes to hours. (Full article)

Containment measures

Many countries attempted to slow or stop the spread of COVID-19 by recommending, mandating or prohibiting behaviour changes, while others relied primarily on providing information. Measures ranged from public advisories to stringent lockdowns. Outbreak control strategies are divided into elimination and mitigation. Experts differentiate between" zero-COVID", which is an elimination strategy, and mitigation strategies that attempt to lessen the effects of the virus on society, but which still tolerate some level of transmission within the community. Containment strategies consists of the use of public health measures such as contact tracing, mass testing, border quarantine, lockdowns and mitigation software.These strategies can be pursued sequentially or simultaneously during the acquired immunity phase through natural and vaccine-induced immunity.

Videos

Recent news

25 June 2025 –
The first train from North Korea arrives at the Yaroslavsky railway station in Moscow, Russia, after a five-year pause due to the COVID-19 pandemic. (TASS)
27 May 2025 – COVID-19 pandemic in the United States, COVID-19 vaccine hesitancy in the United States
Department of Health and Human Services secretary Robert F. Kennedy Jr. announces that the United States Centers for Disease Control will remove the COVID-19 vaccine from its list of recommended vaccines for healthy children and pregnant women. (NPR) (Reuters)

Did you know?

No recent additions
(More did you know facts)

Data maps

Economic impact

The COVID-19 pandemic caused far-reaching economic consequences including the COVID-19 recession, the second largest global recession in recent history, decreased business in the services sector during the COVID-19 lockdowns, the 2020 stock market crash (which included the largest single-week stock market decline since the 2008 financial crisis), the impact of COVID-19 on financial markets, the 2021–2023 global supply chain crisis, the 2021–2023 inflation surge, shortages related to the COVID-19 pandemic including the 2020–2023 global chip shortage, panic buying, and price gouging. The pandemic led to governments providing an unprecedented amount of stimulus, and was also a factor in the 2021–2022 global energy crisis and 2022–2023 food crises.

Amidst the recovery and containment, the world economic system was characterized as experiencing significant, broad uncertainty. Economic forecasts and consensus among macroeconomics experts show significant disagreement on the overall extent, long-term effects and projected recovery. A large general increase in prices was attributed to the pandemic. In part, the record-high energy prices were driven by a global surge in demand as the world quit the economic recession caused by COVID-19, particularly due to strong energy demand in Asia. (Full article)

Workplace

Hazard controls for COVID-19 in workplaces are the application of occupational safety and health methodologies for hazard controls to the prevention of COVID-19. Multiple layers of controls are recommended, including measures such as remote work and flextime, personal protective equipment (PPE) and face coverings, social distancing, and enhanced cleaning programs. Recently, engineering controls have been emphasized, particularly stressing the importance of HVAC systems meeting a minimum of 5 air changes per hour with ventilation or MERV-13 filters, as well as the installation of UVGI systems in public areas. (Full article)

Misinformation

False information, including intentional disinformation and conspiracy theories, about the scale of the COVID-19 pandemic and the origin, prevention, diagnosis, and treatment of the disease has been spread through social media, text messaging, and mass media. False information has been propagated by celebrities, politicians, and other prominent public figures. Many countries have passed laws against "fake news", and thousands of people have been arrested for spreading COVID-19 misinformation. The spread of COVID-19 misinformation by governments has also been significant. (Full article)

Testing

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2, the virus that causes COVID-19 and is responsible for the COVID-19 pandemic. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests (serology immunoassays) instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate. (Full article)

Vaccine research

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

The COVID‑19 vaccines are widely credited for their role in reducing the spread of COVID‑19 and reducing the severity and death caused by COVID‑19. Many countries implemented phased distribution plans that prioritized those at highest risk of complications, such as the elderly, and those at high risk of exposure and transmission, such as healthcare workers. (Full article)

Drug research

COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID-19). From early 2020 through 2021, several hundred drug companies, biotechnology firms, university research groups, and health organizations were developing therapeutic candidates for COVID-19 disease in various stages of preclinical or clinical research (506 total candidates in April 2021), with 419 potential COVID-19 drugs in clinical trials, as of April 2021. (Full article)

Long COVID

Long COVID or long-haul COVID is a group of health problems persisting or developing after an initial period of COVID-19 infection. Symptoms can last weeks, months or years and are often debilitating. The World Health Organization defines long COVID as starting three months after the initial COVID-19 infection, but other agencies define it as starting at four weeks after the initial infection.

The causes of long COVID are not yet fully understood. Hypotheses include lasting damage to organs and blood vessels, problems with blood clotting, neurological dysfunction, persistent virus or a reactivation of latent viruses and autoimmunity. Diagnosis of long COVID is based on (suspected or confirmed) COVID-19 infection or symptoms—and by excluding alternative diagnoses. (Full article)

Images

Topics

Get involved!

Get involved by joining WikiProject COVID-19. We discuss collaborations and all manner of issues on our talk page. As of 10 August 2025, there are 2,499 articles within the project's scope. A full list is available here.

Categories

Select [►] to view subcategories

COVID-19
COVID-19 pandemic templates

References

  1. ^ a b c Mathieu, Edouard; Ritchie, Hannah; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Hasell, Joe; Macdonald, Bobbie; Dattani, Saloni; Beltekian, Diana; Ortiz-Ospina, Esteban; Roser, Max (2020–2024). "Coronavirus Pandemic (COVID-19)". Our World in Data. Retrieved 2025-08-06.

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: